Supplementary Figure S1 from Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
Year: 2024
Type: supplementary-materials
Abstract: OC cells are highly sensitive to NTX301 treatment.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4392863255
